Company Monitoring Page for Gilead

latest headlines for company on cafepharma

Roche, Reloaded
Investopedia
Wed, 05/22/13 - 09:22 am
Tags:
Roche, Gilead, Merck, Bristol-Myers Squibb, JNJ
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
Tags:
drug approvals, GSK, Dolutegravir, Trametenib, Auxilium, Xiaflex, Delcath, Melblez, Seattle Genetics, Adcetris, Antares, Otrexup, Amag Pharmaceuticals, Feraheme, Cubist Pharmaceuticals, Entereg, Gilead, sofosbuvir, Amarin, Vascepa, Merck, suvorexant, Valeant Pharmaceuticals, efinaconazole, Depomed, Sefelsa, Zogenix, Zohydro, dabrafenib, tivozanib, Aveo Pharmaceuticals
Will Influenza A H7N9 Generate Opportunities For Pharma?
Seeking Alpha
Tue, 05/21/13 - 10:58 am
Tags:
H7N9, Flu, Gilead, GSK, Novavax, Novartis, Roche, Sanofi
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
Tags:
leukemia, Sprycel, Bristol-Myers Squibb, Gleevec, Novartis, Iclusig, Ariad Pharmaceuticals, Bosulif, Pfizer, Erwinaze, Jazz Pharmaceuticals, Idelalisib, Gilead, ibrutinib, Pharmacyclics
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Tags:
Gilead, ASCO, JNJ, Pharmacyclics, idelalisab, ibrutinib, CLL
5 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Wed, 05/15/13 - 02:50 pm
Tags:
Gilead, Bristol-Myers Squibb, JNJ, Merck, Pfizer
Racing Toward the Next Hepatitis C Drug Approval
Motley Fool
Wed, 05/15/13 - 09:06 am
Tags:
hepatitis C, JNJ, Gilead, Merck, Roche, Vertex Pharmaceuticals
Gilead's Hepatitis C Drug Sofosbuvir Offers Upside
Seeking Alpha
Thu, 05/9/13 - 09:40 am
Tags:
hepatitis C, sofosbuvir, Gilead
Leading Biotechs Act Well But Be Careful Not To Chase
Investors.com
Tue, 05/7/13 - 11:39 am
Tags:
Biogen Idec, Regeneron, Amgen, Celgene, Gilead
Gilead's HCV Drug Pipeline Outshines Weak Q1 Results
Investors.com
Fri, 05/3/13 - 08:54 am
Tags:
earnings, Gilead, hepatitis C
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thu, 05/2/13 - 10:28 am
Tags:
hepatitis C, Gilead, ledipasvir, sofosbuvir
Gilead Sciences Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Thu, 05/2/13 - 10:27 am
Tags:
earnings, Gilead
FDA rejects two Gilead HIV drugs as standalone products
Reuters
Mon, 04/29/13 - 10:49 am
Tags:
FDA, HIV, Gilead, cobicistat, elvitegravir, Stribild
Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg
Mon, 04/29/13 - 10:26 am
Tags:
Gilead, Bristol-Myers Squibb, hepatitis C, declatasvir, sofosbuvir
5 Top Biotechs With Bolting Stocks, Earnings On Tap
Investors.com
Tue, 04/23/13 - 11:34 am
Tags:
earnings, Medicines Company, Celgene, Gilead, Amgen, Biogen Idec
Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com
Tue, 04/23/13 - 11:21 am
Tags:
Gilead, Bristol-Myers Squibb, hepatitis C, sofosbuvir, daclatasvir, asunaprevir, BMS-791325
Gilead announces results from Phase 3 trial evaluating sofosbuvir
Yahoo/Fly on the Wall
Tue, 04/23/13 - 11:06 am
Tags:
Gilead, hepatitis C, sofosbuvir
Whisper Number Impact: Earnings Preview For Gilead Sciences
Seeking Alpha
Mon, 04/22/13 - 02:07 pm
Tags:
Gilead, earnings
Worth Repeating: Vertex Is The Next Gilead Sciences
TheStreet.com
Fri, 04/19/13 - 08:54 am
Tags:
Gilead, Vertex Pharmaceuticals, Kalydeco, VX-661
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
Seeking Alpha
Thu, 04/18/13 - 06:57 pm
Tags:
Arena Pharmaceuticals, Gilead, Biomarin, Acadia, Catalyst Pharmaceutical Partners

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.